Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
There is some empirical evidence that selective serotonin reuptake inhibitors reduce suicidal ideas faster than other antidepressants. These findings are well in line with the theory of a serotonergic hypofunction in suicidal patients. To test this hypothesis the data of a 6-week double-blind control-group study comparing paroxetine versus amitriptyline were analyzed with respect to suicidality. The global antidepressive efficacy was comparable under dosages of 30 mg paroxetine or 150 mg amitriptyline per day. A differentiated analysis failed to confirm the hypothesis of a faster reduction of suicidal cognitions by paroxetine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, of 10 such studies that compared the effects of serotonergic antidepressants to noradrenergic antidepressants on suicidal ideation, five studies favored serotonergic drugs 316-320 , one study favored a noradrenergic drug 321 , and four studies found no difference 322-325 .”
From Suicide and suicide risk (2019) · cites this paper as [323]
Citations
Cites
Monoamine Metabolites in CSF and Suicidal Behavior
Träskman, L. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780310031002 · Cited by 689
Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
Beasley, C. M., Dornseif, B. E., Bosomworth, J. C., Sayler, M. E., Rampey, A. H., Heiligenstein, J. H., Thompson, V. L., Murphy, D. J., & Masica, D. N. (1991) · BMJ · doi:10.1136/bmj.303.6804.685 · Cited by 361
A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients
Muijen, M., Roy, D. H., Silverstone, T., Mehmet, A., & Christie, M. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06353.x · Cited by 110
A double blind comparison of zimelidine and amitriptyline in endogenous depression
Montgomery, S., McAuley, R., Rani, S. J., Roy, D. H., & Montgomery, D. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00735.x · Cited by 105
Antidepressants - Do they Decrease or Increase Suicidality?
Møller, H. J. (1992) · Pharmacopsychiatry · doi:10.1055/s-2007-1014416 · Cited by 56
Double-Blind Multicenter Study of Paroxetine and Amitriptyline in Depressed Inpatients
Möller, H., Berzewski, H., Eckmann, F., Gonzalves, N., Kissling, W., Knorr, W., Ressler, P., Rudolf, G., Steinmeyer, E., Magyar, I., et al. (1993) · Pharmacopsychiatry · doi:10.1055/s-2007-1014346 · Cited by 47
Biological Correlates of Suicidal Behavior
Åsberg, M., & Nordström, P. (1988) · Springer eBooks · doi:10.1007/978-3-642-73358-1_32 · Cited by 47
The Role of Serotonin in Depression and Suicide: Do Serotonin Reuptake Inhibitors Provide a Key?
Wakelin, J. S. (2015) · Advances in biological psychiatry · doi:10.1159/000416219 · Cited by 44
The Advantages of Paroxetine in Different Subgroups of Depression
Montgomery, S. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199206004-00015 · Cited by 31 · cited 1×
“( 1991 ) which could not find a significant difference between this serotonin reuptake inhibitor and its active comparators with respect to suicidality, but not with the pooled data of the paroxetine studies where there was a significant advantage early in treatment for the selective serotonin reuptake inhibitor compa…”
Result5-HT Reuptake Inhibitors, Tricyclic Antidepressants and Suicidal Behaviour
Baldwin, D. S., Bullock, T., Montgomery, D., & Montgomery, S. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199112003-00005 · Cited by 25
Cited by
Turecki, G., Brent, D. A., Gunnell, D., O’Connor, R. C., Oquendo, M. A., Pirkis, J., & Stanley, B. H. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0121-0 · Cited by 1,074
Suicide, suicidality and suicide prevention in affective disorders
Möller, H. J. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s418.15.x · Cited by 127
“These findings could not be confirmed in a multicentre study comparing paroxetine with amitriptyline (54).”
BackgroundGrunebaum, M. F., Ellis, S. P., Duan, N., Burke, A. K., Oquendo, M. A., & John Mann, J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.247 · Cited by 79
Antidepressants and suicidal behaviour in unipolar depression
Yerevanian, B. I., Koek, R. J., Feusner, J. D., Hwang, S., & Mintz, J. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00437.x · Cited by 75
“There were no significant differences between the two medications (20).”
BackgroundParoxetine versus other anti-depressive agents for depression
Purgato, M., Papola, D., Gastaldon, C., Trespidi, C., Magni, L. R., Rizzo, C., Furukawa, T. A., Watanabe, N., Cipriani, A., & Barbui, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006531.pub2 · Cited by 71
Metadata
- Authors
- MOLLER, H.
- Affiliations
- University of Bonn (DE)
- Corresponding author
- MOLLER, H
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 1994-03
- Volume
- 4
- Issue
- 1
- Pages
- 55-59
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2101609405
- Cited by
- 16
- References
- 13
- Citations by year
- 2024: 1 · 2019: 1 · 2016: 1 · 2014: 1
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- European Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- paroxetine, amitriptyline, selective serotonin reuptake inhibitors, suicidal ideation, suicidality, antidepressant efficacy, tricyclic antidepressants, double-blind comparison
- MeSH terms
- Adult, Depressive Disorder, Double-Blind Method, Humans, Psychiatric Status Rating Scales, Suicide, Selective Serotonin Reuptake Inhibitors, Paroxetine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine. https://app.cochat.ai/papers/10.1016/0924-977x(94)90315-8
- The paper
- MOLLER, H. (1994). Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine. European Neuropsychopharmacology. https://doi.org/10.1016/0924-977x(94)90315-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.